Zheng Xing Xing Ye Ri Bao·2025-08-29 08:41Market Overview - The biopharmaceutical sector increased by 0.85% on August 29, with Kangchen Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3857.93, up 0.37%, while the Shenzhen Component Index closed at 12696.15, up 0.99% [1] Top Gainers in Biopharmaceutical Sector - Kangchen Pharmaceutical (603590) closed at 56.17, up 10.01% with a trading volume of 67,100 shares and a transaction value of 366 million [1] - Rongchang Biopharmaceutical (688331) closed at 90.88, up 8.35% with a trading volume of 166,100 shares [1] - Sanofi Biopharmaceutical (688336) closed at 52.60, up 8.01% with a trading volume of 89,900 shares [1] - Baipusais (301080) closed at 58.61, up 7.34% with a trading volume of 42,800 shares [1] - Wanzhe Co. (000534) closed at 17.70, up 6.31% with a trading volume of 382,900 shares [1] Top Losers in Biopharmaceutical Sector - Tibet Pharmaceutical (600211) closed at 47.16, down 3.42% with a trading volume of 193,800 shares and a transaction value of 912 million [2] - Wendi Pharmaceutical (688488) closed at 17.36, down 2.36% with a trading volume of 126,200 shares [2] - Chengda Biopharmaceutical (688739) closed at 27.90, down 2.35% with a trading volume of 50,700 shares [2] Capital Flow Analysis - The biopharmaceutical sector experienced a net outflow of 506 million from institutional investors, while retail investors saw a net inflow of 402 million [2] - The top stocks by net inflow from institutional investors included Rongchang Biopharmaceutical with a net inflow of 127 million [3] - Kangchen Pharmaceutical had a net inflow of 68 million from institutional investors, but also saw outflows from retail investors [3]